Figure 6.
Plaque reduction by marker components: caffeic acid and eupafolin. Caffeic acid and eupafolin were analyzed for antiviral activity against EV71 (a) and CoxA16 (b), using plaque assay.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.